20-Oct-2026 19:41:25
APPLGeneral news
APTUS PHARMA H1 FY27: NET PROFIT UP 191% AT ₹5.08 CR (YOY)
REVENUE UP 240% AT ₹48.92 CR (YOY) EBITDA UP 167% AT ₹7.89 CR (YOY) MARGINS AT 16.1% VS 20.5% (YOY)
Aptus Pharma Limited
20-Oct-2026 19:41:25
REVENUE UP 240% AT ₹48.92 CR (YOY) EBITDA UP 167% AT ₹7.89 CR (YOY) MARGINS AT 16.1% VS 20.5% (YOY)
Aptus Pharma Limited